SCHEMBL7187129

SCHEMBL7187129

C=C(C)Oc1ccc(C(=O)C=Cc2cc(C)c(OC)cc2OC)cc1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.61
PTPN1 P18031 8/20 0.59
TNFRSF1A P19438 1/20 0.56
DPP4 P27487 3/20 0.53
MAPT P10636 3/20 0.52
LMNA P02545 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
HPGD P15428 1/20 0.52
KDM4E B2RXH2 1/20 0.52
ATM Q13315 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
NPC1 O15118 1/20 0.51
ALDH1A1 P00352 1/20 0.51
RAB9A P51151 1/20 0.51
CYP1A1 P04798 1/20 0.51
CYP1B1 Q16678 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7187126 1.00 ABCG2 (0.61) ABCG2PTPN1TNFRSF1ADPP4MAPT
SCHEMBL9111983 0.87 TNFRSF1A (0.72) ABCG2PTPN1TNFRSF1ADPP4MAPT
SCHEMBL9111986 0.87 TNFRSF1A (0.72) ABCG2PTPN1TNFRSF1ADPP4MAPT
SCHEMBL7806523 0.85 ABCG2 (0.80) ABCG2PTPN1TNFRSF1AMAPTLMNA
SCHEMBL7177829 0.85 TNFRSF1A (0.78) ABCG2TNFRSF1AMAPTLMNASMN1; SMN2
SCHEMBL7806526 0.85 ABCG2 (0.80) ABCG2PTPN1TNFRSF1AMAPTLMNA
SCHEMBL7177825 0.85 TNFRSF1A (0.78) ABCG2TNFRSF1AMAPTLMNASMN1; SMN2
SCHEMBL7177707 0.85 PTPN1 (0.70) ABCG2PTPN1TNFRSF1ADPP4CYP1A1
SCHEMBL7188820 0.85 DPP4 (0.48) ABCG2PTPN1DPP4MAPTLMNA
SCHEMBL7177703 0.85 PTPN1 (0.70) ABCG2PTPN1TNFRSF1ADPP4CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed